Company · CIK 0000872589 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
REGENERON PHARMACEUTICALS, INC. · REGN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2015 FGMForm 4 → | Nov 9, 5:10 pm EST | Neil StahlEVP Research and Development | 158,899 | $226.05 | $35,693,709 | 64,130 | — | plan? late |
| May 27, 2015 SForm 4 → | May 29, 4:19 pm EDT | George L SingDirector | 5,000 | $515.00 | $2,575,000 | 112,772 | −4.25% | plan? |
| May 27, 2015 MForm 4 → | May 29, 4:19 pm EDT | George L SingDirector | 5,000 | $19.69 | $98,450 | 117,772 | — | plan? |
| May 27, 2015 SForm 4 → | May 27, 4:02 pm EDT | Robert Alexander IngramDirector | 1,379 | $513.39 | $707,965 | 1,500 | −47.9% | plan? |
| May 26, 2015 SForm 4 → | May 26, 4:32 pm EDT | Daniel P Van PlewSVP & General Mgr Industrial O | 18,370 | $508.42 | $9,339,737 | 0 | −100% | plan? |
| May 22, 2015 FMForm 4 → | May 27, 4:02 pm EDT | Robert Alexander IngramDirector | 10,455 | $374.31 | $3,913,391 | 2,879 | — | plan? |
| May 22, 2015 FMForm 4 → | May 26, 4:32 pm EDT | Daniel P Van PlewSVP & General Mgr Industrial O | 61,730 | $199.17 | $12,294,574 | 18,370 | — | plan? |
| May 22, 2015 SForm 4 → | May 26, 4:31 pm EDT | Douglas S McCorkleVP Controller and Asst Treasur | 13,000 | $515.60 | $6,702,800 | 4,481 | −74.4% | plan? |
| May 22, 2015 MForm 4 → | May 26, 4:31 pm EDT | Douglas S McCorkleVP Controller and Asst Treasur | 13,464 | $174.01 | $2,342,902 | 4,945 | — | plan? |
| May 22, 2015 SForm 4 → | May 26, 4:30 pm EDT | Joseph L GoldsteinDirector | 4,000 | $514.28 | $2,057,100 | 20,000 | −16.7% | plan? |
| May 19, 2015 CForm 4 → | May 20, 4:13 pm EDT | Joseph L GoldsteinDirector | 20,000 | — | — | 24,000 | — | plan? |
| May 15, 2015 SForm 4 → | May 18, 4:50 pm EDT | Michael S BrownDirector | 5,000 | $495.00 | $2,475,000 | 0 | −100% | plan? |
| May 15, 2015 MForm 4 → | May 18, 4:50 pm EDT | Michael S BrownDirector | 5,000 | $57.11 | $285,550 | 5,000 | — | plan? |
| Apr 8, 2015 FMForm 4 → | Apr 9, 4:03 pm EDT | Robert E LandrySVP Finance & CFO | 17,901 | $350.73 | $6,278,500 | 7,099 | — | plan? |
| Mar 25, 2015 MForm 4 → | Mar 26, 4:21 pm EDT | Joseph J LarosaSVP General Counsel and Secret | 3,097 | $59.20 | $183,342 | 15,067 | — | plan? |
| Mar 25, 2015 SForm 4 → | Mar 26, 4:20 pm EDT | Charles A BakerDirector | 5,000 | $454.96 | $2,274,785 | 9,000 | −35.7% | plan? |
| Mar 25, 2015 MForm 4 → | Mar 26, 4:20 pm EDT | Charles A BakerDirector | 5,000 | $18.61 | $93,050 | 14,000 | — | plan? |
| Mar 24, 2015 SForm 4 → | Mar 25, 4:07 pm EDT | Michael S AbermanSVP Strategy Investor Relation | 4,843 | $478.99 | $2,319,738 | 12,498 | −27.9% | plan? |
| Mar 23, 2015 FForm 4 → | Mar 25, 4:07 pm EDT | Michael S AbermanSVP Strategy Investor Relation | 5,157 | $476.50 | $2,457,311 | 17,341 | — | plan? |
| Mar 18, 2015 SForm 4 → | Mar 19, 4:05 pm EDT | Michael S AbermanSVP Strategy Investor Relation | 3,442 | $465.00 | $1,600,542 | 22,498 | −13.3% | plan? |
| Mar 17, 2015 FMForm 4 → | Mar 19, 4:05 pm EDT | Michael S AbermanSVP Strategy Investor Relation | 15,456 | $137.92 | $2,131,751 | 25,940 | — | plan? |
| Mar 17, 2015 SForm 4 → | Mar 18, 6:03 pm EDT | Robert J TerifaySVP Commercial | 10,993 | $451.01 | $4,957,907 | 20,029 | −35.4% | plan? |
| Mar 16, 2015 FMForm 4 → | Mar 18, 6:03 pm EDT | Robert J TerifaySVP Commercial | 37,757 | $177.30 | $6,694,370 | 31,022 | — | plan? |
| Mar 16, 2015 SForm 4 → | Mar 17, 4:57 pm EDT | Joseph J LarosaSVP General Counsel and Secret | 18,311 | $450.00 | $8,239,950 | 10,000 | −64.7% | plan? |
| Mar 16, 2015 MForm 4 → | Mar 17, 4:57 pm EDT | Joseph J LarosaSVP General Counsel and Secret | 20,281 | $59.20 | $1,200,635 | 11,970 | — | plan? |
| Feb 27, 2015 SForm 4 → | Feb 27, 4:31 pm EST | Douglas S McCorkleVP Controller and Asst Treasur | 3,000 | $416.24 | $1,248,720 | 4,481 | −40.1% | plan? |
| Feb 26, 2015 SForm 4 → | Feb 27, 4:32 pm EST | Marc Tessier-LavigneDirector | 3,000 | $421.95 | $1,265,864 | 1,187 | −71.7% | plan? |
| Feb 26, 2015 MForm 4 → | Feb 27, 4:32 pm EST | Marc Tessier-LavigneDirector | 3,000 | $50.91 | $152,730 | 4,187 | — | plan? |
| Feb 24, 2015 SForm 4 → | Feb 25, 4:02 pm EST | Michael S AbermanSVP Strategy Investor Relation | 3,374 | $418.48 | $1,411,952 | 18,600 | −15.4% | plan? |
| Feb 24, 2015 SForm 4 → | Feb 25, 4:01 pm EST | Robert J TerifaySVP Commercial | 11,173 | $423.67 | $4,733,665 | 20,029 | −35.8% | plan? |
| Feb 23, 2015 FMForm 4 → | Feb 25, 4:02 pm EST | Michael S AbermanSVP Strategy Investor Relation | 11,626 | $171.63 | $1,995,405 | 21,974 | — | plan? |
| Feb 23, 2015 FMForm 4 → | Feb 25, 4:01 pm EST | Robert J TerifaySVP Commercial | 37,577 | $170.22 | $6,396,270 | 31,202 | — | plan? |
| Feb 23, 2015 SForm 4 → | Feb 24, 5:08 pm EST | Daniel P Van PlewSVP & General Mgr Industrial O | 9,431 | $427.82 | $4,034,754 | 18,705 | −33.5% | plan? |
| Feb 20, 2015 SForm 4 → | Feb 24, 5:08 pm EST | George L SingDirector | 15,000 | $423.12 | $6,346,800 | 112,772 | −11.7% | plan? |
| Feb 20, 2015 MForm 4 → | Feb 24, 5:08 pm EST | George L SingDirector | 15,000 | $18.61 | $279,150 | 127,772 | — | plan? |
| Feb 20, 2015 FMForm 4 → | Feb 24, 5:08 pm EST | Daniel P Van PlewSVP & General Mgr Industrial O | 30,569 | $160.74 | $4,913,654 | 28,136 | — | plan? |
| Feb 20, 2015 SForm 4 → | Feb 23, 4:07 pm EST | Michael S BrownDirector | 1,000 | $422.72 | $422,720 | 0 | −100% | plan? |
| Feb 20, 2015 MForm 4 → | Feb 23, 4:07 pm EST | Michael S BrownDirector | 1,000 | $57.11 | $57,110 | 1,000 | — | plan? |
| Feb 20, 2015 SForm 4 → | Feb 23, 4:06 pm EST | Arthur F RyanDirector | 29,250 | $423.01 | $12,372,908 | 47,500 | −38.1% | plan? |
| Feb 20, 2015 MForm 4 → | Feb 23, 4:06 pm EST | Arthur F RyanDirector | 29,250 | $125.79 | $3,679,498 | 76,750 | — | plan? |
| Feb 20, 2015 SForm 4 → | Feb 20, 4:44 pm EST | Joseph L GoldsteinDirector | 5,000 | $423.65 | $2,118,262 | 4,000 | −55.6% | plan? |
| Feb 20, 2015 MForm 4 → | Feb 20, 4:44 pm EST | Joseph L GoldsteinDirector | 5,000 | $177.82 | $889,100 | 9,000 | — | plan? |
| Feb 17, 2015 SForm 4 → | Feb 18, 4:40 pm EST | Michael S AbermanSVP Strategy Investor Relation | 3,692 | $404.46 | $1,493,266 | 18,600 | −16.6% | plan? |
| Feb 13, 2015 FMForm 4 → | Feb 18, 4:40 pm EST | Michael S AbermanSVP Strategy Investor Relation | 11,308 | $151.31 | $1,711,006 | 22,292 | — | plan? |
| Jan 6, 2015 GForm 4 → | Nov 4, 4:05 pm EST | P Roy VagelosChairman of the Board, Director | 1,387 | — | — | 154,390 | — | plan? late |
| Jan 2, 2015 SForm 4 → | Jan 5, 4:56 pm EST | Leonard S SchleiferPresident & CEO, Director | 1,500 | $410.58 | $615,867 | 0 | −100% | plan? |
| Jan 2, 2015 CForm 4 → | Jan 5, 4:56 pm EST | Leonard S SchleiferPresident & CEO, Director | 1,500 | — | — | 1,500 | — | plan? |
| Jan 2, 2015 SForm 4 → | Jan 5, 4:28 pm EST | Peter PowchikSVP Clinical Development & Reg | 10,822 | $414.08 | $4,481,214 | 10,711 | −50.3% | plan? |
| Dec 31, 2014 FMForm 4 → | Jan 5, 2015, 4:28 pm EST | Peter PowchikSVP Clinical Development & Reg | 39,178 | $182.58 | $7,153,145 | 21,533 | — | plan? |
| Nov 24, 2014 GForm 4 → | Jan 5, 2015, 4:13 pm EST | Michael S BrownDirector | 2,000 | — | — | 18,349 | — | plan? late |
| May 16, 2014 GForm 4 → | Jan 5, 2015, 5:26 pm EST | Arthur F RyanDirector | 2,355 | — | — | 47,500 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2016 MForm 4 → | Dec 14, 5:41 pm EST | Charles A BakerDirector | 3,000 | — | — | 2,000 | — | |
| Nov 14, 2016 MForm 4 → | Nov 15, 4:08 pm EST | Joseph L GoldsteinDirector | 2,125 | — | — | 8,500 | — | |
| Nov 7, 2016 MForm 4 → | Nov 9, 4:10 pm EST | P Roy VagelosChairman of the Board, Director | 76,895 | — | — | 0 | — | |
| Sep 9, 2016 AForm 4 → | Sep 12, 4:25 pm EDT | Huda Y ZoghbiDirector | 15,353 | — | — | 15,353 | — | |
| Sep 9, 2016 AForm 4 → | Sep 12, 4:24 pm EDT | Bonnie L BasslerDirector | 15,353 | — | — | 15,353 | — | |
| Jul 29, 2016 MForm 4 → | Aug 1, 4:04 pm EDT | Joseph L GoldsteinDirector | 2,125 | — | — | 10,625 | — | |
| May 17, 2016 MForm 4 → | May 19, 4:26 pm EDT | Daniel P Van PlewEVP & General Mgr Industrial O | 9,460 | — | — | 32,735 | — | |
| May 12, 2016 MForm 4 → | May 13, 4:40 pm EDT | P Roy VagelosChairman of the Board, Director | 230,684 | — | — | 76,895 | — | |
| Apr 6, 2016 MForm 4 → | Apr 7, 4:19 pm EDT | Joseph L GoldsteinDirector | 1,000 | — | — | 0 | — | |
| Apr 1, 2016 MForm 4 → | Apr 4, 4:16 pm EDT | Joseph L GoldsteinDirector | 2,000 | — | — | 1,000 | — | |
| Mar 21, 2016 MForm 4 → | Mar 21, 4:27 pm EDT | Joseph L GoldsteinDirector | 2,000 | — | — | 3,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:02 pm EST | Michael S BrownDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:02 pm EST | Joseph L GoldsteinDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:02 pm EST | Arthur F RyanDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:02 pm EST | George L SingDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:01 pm EST | Marc Tessier-LavigneDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:01 pm EST | Charles A BakerDirector | 9,212 | — | — | 9,212 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:01 pm EST | Christine A PoonDirector | 9,212 | — | — | 9,212 | — | |
| Dec 29, 2015 MForm 4 → | Dec 29, 7:44 pm EST | Douglas S McCorkleVP Controller and Asst Treasur | 3,954 | — | — | 0 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:28 pm EST | Michael S AbermanSVP Strategy Investor Relation | 29,500 | — | — | 25,500 | — | |
| Dec 16, 2015 AForm 4 → | Dec 18, 4:28 pm EST | Robert E LandrySVP Finance & CFO | 28,900 | — | — | 28,900 | — | |
| Dec 16, 2015 AForm 4 → | Dec 18, 4:28 pm EST | Joseph J LarosaSVP General Counsel and Secret | 28,900 | — | — | 28,900 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:28 pm EST | Douglas S McCorkleVP Controller and Asst Treasur | 5,721 | — | — | 3,800 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:27 pm EST | Peter PowchikSVP Clinical Development & Reg | 26,921 | — | — | 25,000 | — | |
| Dec 16, 2015 AForm 4 → | Dec 18, 4:27 pm EST | Leonard S SchleiferPresident & CEO, Director | 172,723 | — | — | 172,723 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:27 pm EST | Neil StahlEVP Research and Development | 70,559 | — | — | 68,638 | — | |
| Dec 16, 2015 AForm 4 → | Dec 18, 4:27 pm EST | Robert J TerifaySVP Commercial | 40,000 | — | — | 40,000 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:27 pm EST | Daniel P Van PlewSVP & General Mgr Industrial O | 41,921 | — | — | 40,000 | — | |
| Dec 16, 2015 AMForm 4 → | Dec 18, 4:26 pm EST | George YancopoulosPresident Regeneron Laboratori, Director | 148,736 | — | — | 146,815 | — | |
| Dec 16, 2015 AForm 4 → | Dec 18, 4:26 pm EST | P Roy VagelosChairman of the Board, Director | 92,123 | — | — | 92,123 | — | |
| Dec 10, 2015 MForm 4 → | Dec 11, 4:14 pm EST | Michael S BrownDirector | 3,000 | — | — | 12,000 | — | |
| Nov 18, 2015 MForm 4 → | Nov 20, 4:04 pm EST | George L SingDirector | 3,000 | — | — | 7,000 | — | |
| Nov 6, 2015 MForm 4 → | Nov 10, 4:06 pm EST | Daniel P Van PlewSVP & General Mgr Industrial O | 11,186 | — | — | 42,195 | — | |
| Nov 5, 2015 MForm 4 → | Nov 9, 5:10 pm EST | Neil StahlEVP Research and Development | 100,000 | — | — | 46,736 | — | |
| Oct 30, 2015 MForm 4 → | Nov 3, 4:20 pm EST | George YancopoulosPresident Regeneron Laboratori, Director | 182,818 | — | — | 0 | — | |
| Sep 21, 2015 MForm 4 → | Sep 22, 2:39 pm EDT | Michael S BrownDirector | 3,000 | — | — | 0 | — | |
| Sep 17, 2015 MForm 4 → | Sep 18, 4:06 pm EDT | Charles A BakerDirector | 5,000 | — | — | 5,000 | — | |
| Sep 2, 2015 MForm 4 → | Sep 3, 4:59 pm EDT | Leonard S SchleiferPresident & CEO, Director | 7,226 | — | — | 0 | — | |
| Sep 1, 2015 MForm 4 → | Sep 2, 4:04 pm EDT | Joseph J LarosaSVP General Counsel and Secret | 1,689 | — | — | 0 | — | |
| Aug 13, 2015 MForm 4 → | Aug 17, 4:01 pm EDT | Peter PowchikSVP Clinical Development & Reg | 60,361 | — | — | 30,000 | — | |
| Aug 11, 2015 MForm 4 → | Aug 12, 4:45 pm EDT | Christine A PoonDirector | 470 | — | — | 12,280 | — | |
| Aug 6, 2015 MForm 4 → | Aug 7, 6:15 pm EDT | Alfred G GilmanDirector | 5,000 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 7, 6:14 pm EDT | Robert J TerifaySVP Commercial | 32,500 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 7, 6:13 pm EDT | Daniel P Van PlewSVP & General Mgr Industrial O | 8,700 | — | — | 53,381 | — | |
| Aug 5, 2015 MForm 4 → | Aug 6, 9:00 pm EDT | Robert E LandrySVP Finance & CFO | 4,000 | — | — | 66,000 | — | |
| Aug 5, 2015 MForm 4 → | Aug 5, 8:58 pm EDT | Douglas S McCorkleVP Controller and Asst Treasur | 5,000 | — | — | 15,000 | — | |
| Aug 5, 2015 MForm 4 → | Aug 5, 8:55 pm EDT | Marc Tessier-LavigneDirector | 5,000 | — | — | 5,000 | — | |
| Jul 31, 2015 CForm 4 → | Aug 3, 7:23 pm EDT | Alfred G GilmanDirector | 8,912 | — | — | 0 | — | |
| May 27, 2015 MForm 4 → | May 29, 4:19 pm EDT | George L SingDirector | 5,000 | — | — | 10,000 | — | |
| May 22, 2015 MForm 4 → | May 27, 4:02 pm EDT | Robert Alexander IngramDirector | 6,667 | — | — | 13,333 | — | |
| May 22, 2015 MForm 4 → | May 26, 4:32 pm EDT | Daniel P Van PlewSVP & General Mgr Industrial O | 40,050 | — | — | 57,986 | — | |
| May 22, 2015 MForm 4 → | May 26, 4:31 pm EDT | Douglas S McCorkleVP Controller and Asst Treasur | 13,464 | — | — | 13,000 | — | |
| May 19, 2015 CForm 4 → | May 20, 4:13 pm EDT | Joseph L GoldsteinDirector | 20,000 | — | — | 0 | — | |
| May 15, 2015 MForm 4 → | May 18, 4:50 pm EDT | Michael S BrownDirector | 5,000 | — | — | 3,000 | — | |
| Apr 8, 2015 MForm 4 → | Apr 9, 4:03 pm EDT | Robert E LandrySVP Finance & CFO | 10,000 | — | — | 70,000 | — | |
| Mar 25, 2015 MForm 4 → | Mar 26, 4:21 pm EDT | Joseph J LarosaSVP General Counsel and Secret | 3,097 | — | — | 1,689 | — | |
| Mar 25, 2015 MForm 4 → | Mar 26, 4:20 pm EDT | Charles A BakerDirector | 5,000 | — | — | 10,000 | — | |
| Mar 17, 2015 MForm 4 → | Mar 19, 4:05 pm EDT | Michael S AbermanSVP Strategy Investor Relation | 11,398 | — | — | 14,168 | — | |
| Mar 16, 2015 MForm 4 → | Mar 18, 6:03 pm EDT | Robert J TerifaySVP Commercial | 24,375 | — | — | 29,236 | — | |
| Mar 16, 2015 MForm 4 → | Mar 17, 4:57 pm EDT | Joseph J LarosaSVP General Counsel and Secret | 20,281 | — | — | 54,933 | — | |
| Feb 26, 2015 MForm 4 → | Feb 27, 4:32 pm EST | Marc Tessier-LavigneDirector | 3,000 | — | — | 9,279 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 4:02 pm EST | Michael S AbermanSVP Strategy Investor Relation | 7,500 | — | — | 7,500 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 4:01 pm EST | Robert J TerifaySVP Commercial | 24,375 | — | — | 53,611 | — | |
| Feb 20, 2015 MForm 4 → | Feb 24, 5:08 pm EST | George L SingDirector | 15,000 | — | — | 0 | — | |
| Feb 20, 2015 MForm 4 → | Feb 24, 5:08 pm EST | Daniel P Van PlewSVP & General Mgr Industrial O | 20,000 | — | — | 17,895 | — | |
| Feb 20, 2015 MForm 4 → | Feb 23, 4:07 pm EST | Michael S BrownDirector | 1,000 | — | — | 8,000 | — | |
| Feb 20, 2015 MForm 4 → | Feb 23, 4:06 pm EST | Arthur F RyanDirector | 29,250 | — | — | 8,500 | — | |
| Feb 20, 2015 MForm 4 → | Feb 20, 4:44 pm EST | Joseph L GoldsteinDirector | 5,000 | — | — | 5,000 | — | |
| Feb 13, 2015 MForm 4 → | Feb 18, 4:40 pm EST | Michael S AbermanSVP Strategy Investor Relation | 7,500 | — | — | 21,668 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 5:26 pm EST | Arthur F RyanDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 CForm 4 → | Jan 5, 4:56 pm EST | Leonard S SchleiferPresident & CEO, Director | 1,500 | — | — | 15,775 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:31 pm EST | Marc Tessier-LavigneDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:25 pm EST | Charles A BakerDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:23 pm EST | Christine A PoonDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:16 pm EST | George L SingDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:15 pm EST | Alfred G GilmanDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:14 pm EST | Joseph L GoldsteinDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:13 pm EST | Michael S BrownDirector | 10,838 | — | — | 10,838 | — | |
| Jan 2, 2015 AForm 4 → | Jan 5, 4:12 pm EST | Robert Alexander IngramDirector | 10,838 | — | — | 10,838 | — | |
| Dec 31, 2014 MForm 4 → | Jan 5, 2015, 4:28 pm EST | Peter PowchikSVP Clinical Development & Reg | 25,000 | — | — | 37,079 | — |